Acasti Pharma Inc. (CVE:ACST – Get Rating)’s share price dropped 4.5% during mid-day trading on Tuesday . The company traded as low as C$1.05 and last traded at C$1.05. Approximately 4,660 shares traded hands during mid-day trading, a decline of 61% from the average daily volume of 12,078 shares. The stock had previously closed at C$1.10.
Acasti Pharma Stock Performance
The stock has a market capitalization of C$46.84 million and a PE ratio of -1.76. The company has a debt-to-equity ratio of 0.52, a current ratio of 9.86 and a quick ratio of 9.41. The business’s fifty day moving average price is C$0.70 and its 200-day moving average price is C$0.87.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Read More
- Insiders Buy Archer Aviation, Is This Stock About To Take Off?
- Intuit Is About To Make a Move, But Which Way?
- 3 Late January Earnings Plays With Pop Potential
- Low-Priced Stocks Still Paying Dividends
- Why is the Chipotle Stock Price Surging This Week?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
